These stocks are crushing the market this year, and there is likely plenty of upside ahead. One great thing about the ...

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were ...

CRISPR Therapeutics and BioNTech have climbed along with many of their peers over the past week. Both are innovative biotechs ...

Healthcare stocks are up despite a government shutdown as AI transforms drug discovery, diagnostics, and robotics. Click here ...

In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, ...

While tariff threats and drug pricing pressures weighed on healthcare stocks' outlook, some parts of the sector are beginning to stage a recovery. TD Asset Management's Ram Sampath discusses ...

BofA Global Research is now overweight the stock market’s healthcare sector, saying in a research note on Tuesday that it has ...

From Aug. 18 through the first hour of trading on Sept. 18, shares of Nektar Therapeutics shot 108% higher. Investors have ...

U.S. healthcare shares rose on Wednesday as Georgia elections appeared to shift Senate control to Democrats - long considered a risk for the sector - with investors factoring in support for current ...

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $127.89, denoting a -2.4% move from the preceding trading day.

On September 26, Geoff Meacham, Managing Director of Citi Research, appeared on CNBC’s “Closing Bell Overtime” to talk about ...

(Reuters) -European shares opened flat on Friday as losses in healthcare stocks were offset by gains in bank and automobile ...